III型选择性宫内生长受限的单绒毛膜双胎妊娠结局
该多中心回顾性队列纳入328例III型sIUGR单绒毛膜双羊膜囊双胎,非医源性宫内死亡胎儿风险从16周的8.1%降至28.4周后的不足2%、32.6周后的不足1%;无并发症者计划32周分娩时复合不良新生儿结局风险为29.0%,继续至34周者宫内死亡风险0.7%、复合不良新生儿结局风险11%。
要点
- III型sIUGR非医源性宫内死亡胎儿风险从16周8.1%降至28.4周后不足2%、32.6周后不足1%。
- 无并发症III型sIUGR计划32周分娩时复合不良新生儿结局风险为29.0%(31/107例新生儿)。
- 继续至34周者宫内死亡风险0.7%、复合不良新生儿结局风险11%。
诊断标准与关键数值
- 复合不良新生儿结局定义为新生儿死亡、复苏期后侵入性通气、培养证实的脓毒症、需治疗的坏死性小肠结肠炎、I级以上脑室内出血、II期以上早产儿视网膜病变或囊性室周白质软化。
- 非医源性宫内死亡胎儿风险从16周的8.1%(95%CI 5.95-10.26%)降至28.4周后的不足2%(95%CI 0.59-2.79%)和32.6周后的不足1%(95%CI -0.30至1.89%)。
- 无并发症III型sIUGR计划32周分娩时复合不良新生儿结局风险为29.0%(31/107例新生儿),继续至34周者宫内死亡风险0.7%、复合不良新生儿结局风险11%。
临床应用与阅片要点
- 无并发症III型sIUGR本队列中分娩一般计划在32周,该时点复合不良新生儿结局风险为29.0%(31/107例新生儿)。
- 继续至34周的妊娠宫内死亡风险0.7%、复合不良新生儿结局风险11%。
- 作者认为应进一步识别胎儿死亡预测因素和最佳产前监测策略,以筛选可安全继续妊娠至33周以后的队列。
局限性
- 本文为回顾性研究。
- 作者在结论中提出需进一步努力识别胎儿死亡预测因素和最佳产前监测策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Type-III selective intrauterine growth restriction (sIUGR) is associated with a high and unpredictable risk of fetal death and fetal brain injury. The objective of this study was to describe the prospective risk of fetal death and the risk of adverse neonatal outcome in a cohort of twin pregnancies complicated by Type-III sIUGR and treated according to up-to-date guidelines.
METHODS: We reviewed retrospectively all monochorionic diamniotic twin pregnancies complicated by Type-III sIUGR managed at nine fetal centers over a 12-year period. Higher-order multiple gestations and pregnancies with major fetal anomalies or other monochorionicity-related complications at initial presentation were excluded. Data on fetal and neonatal outcomes were collected and management strategies reviewed. Composite adverse neonatal outcome was defined as neonatal death, invasive ventilation beyond the resuscitation period, culture-proven sepsis, necrotizing enterocolitis requiring treatment, intraventricular hemorrhage Grade > I, retinopathy of prematurity Stage > II or cystic periventricular leukomalacia. The prospective risk of intrauterine death (IUD) and the risk of neonatal complications according to gestational age were evaluated.
RESULTS: We collected data on 328 pregnancies (656 fetuses). After exclusion of pregnancies that underwent selective reduction (n = 18 (5.5%)), there were 51/620 (8.2%) non-iatrogenic IUDs in 35/310 (11.3%) pregnancies. Single IUD occurred in 19/328 (5.8%) pregnancies and double IUD in 16/328 (4.9%). The prospective risk of non-iatrogenic IUD per fetus declined from 8.1% (95% CI, 5.95-10.26%) at 16 weeks, to less than 2% (95% CI, 0.59-2.79%) after 28.4 weeks and to less than 1% (95% CI, -0.30 to 1.89%) beyond 32.6 weeks. In otherwise uncomplicated pregnancies with Type-III sIUGR, delivery was generally planned at 32 weeks, at which time the risk of composite adverse neonatal outcome was 29.0% (31/107 neonates). In twin pregnancies that continued to 34 weeks, there was a very low risk of IUD (0.7%) and a low risk of composite adverse neonatal outcome (11%).
CONCLUSIONS: In this cohort of twin pregnancies complicated by Type-III sIUGR and treated at several tertiary fetal centers, the risk of fetal death was lower than that reported previously. Further efforts should be directed at identifying predictors of fetal death and optimal antenatal surveillance strategies to select a cohort of pregnancies that can continue safely beyond 33 weeks' gestation. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Shinar S, Xing W, Pruthi V, et al. Outcome of monochorionic twin pregnancy complicated by Type-III selective intrauterine growth restriction. Ultrasound Obstet Gynecol. 2021. PMID: 33073883. doi:10.1002/uog.23515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。